Arkolith/Insider Trading/LHDX/Form 4

Engelson Erik T.

President and Chief Executive, DirectorLucira Health, Inc. (LHDX) · full profile →Form 4 · filed Mar 13, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$657K
Net Open-Market Flow
-$657K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2023Sell(S)575K$1.03$592K83K
Mar 3, 2023Option exercise(M)575K$0.82$471K658K
Mar 3, 2023Sell(S)60K$1.09$65K23K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2023Option exercise(M)575K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-018261) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML